Fig. 2From: Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrainsCT26 tumor volume in the three BALB/c substrains treated with cisplatin. The size of solid tumor formed in the syngeneic model was measured using a caliper from days 1 to 14, although significant changes were detected from day 7 to day 14. Five to six mice per group were used for measurement of tumor size; the volume of tumor was calculated in duplicate for each tumor. Data represent the mean ± SD. *, p < 0.05 compared to the No treated group. #, p < 0.05 compared to the Vehicle treated groupBack to article page